DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT substitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.

NOTE: The haematology contents of this resource is currently under review and in the process of being updated.

Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20260820 (AU)

283
Gene and protein biomarkers

82
Combination biomarkers

14
Complex biomarkers

1277
Simple mutations

490
Variant groups

207
Protein expressions

185
Amplification deletions

368
Fusions and Rearrangements

6
Splice variants

8
Methylations

28
Germline mutations

55
Common cancers

82
T1

96
T2

201
T3

342
T4

10
R1

182
R2

26
Less common cancers

19
T1

15
T2

50
T3

135
T4

0
R1

23
R2

197
Rare cancers

38
T1

48
T2

148
T3

422
T4

6
R1

157
R2

© 2020-2026, Garvan Institute of Medical Research, University of Sydney, and Omico
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.